No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population

NeuroReport

Volumn 10, Issue 1, 1999, Pages 57-60

  Lin, Ching Hua ^b   Tsai, Shih Jen ^a   Yu, Younger W Y ^b   Song, Hsiu Li ^a   Tu, Pei Chi ^a   Sim, Cho Boon ^b   Hsu, Chiu Peng ^b   Yang, Kuan Hung ^b   Hong, Chen Jee ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Association study; Clozapine; Schizophrenia; Serotonin 5 HT(2A) receptor gene

Indexed keywords

CLOZAPINE; DNA; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; RECEPTOR GENE; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

EID: 0002964661     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199901180-00011     Document Type: Article

References (25)

1. Meltzer HY. J Clin Psychiatry 55 (suppl. B), 47-52 (1994).
2. Arora RC and Meltzer HY. J Neural Transm 85, 19-29 (1991).
3. Hashimoto T, Kitamura N, Kajimoto Y et al. Psychopharmacology 112 (suppl. 1), S35-S39 (1993).
4. Burnet PW, Eastwood SL and Harrison PJ. Neuropsychopharmacology 15, 442-455 (1996).
5. Gelders Y, Ceulemans DLS, Hoppenbrouwers ML et al. Fourth World Congress of Biological Psychiatry (Report). Philadelphia, PA. 1985: p. 338.
6. Chen K, Yang W, Grimsby J et al. Mol Brain Res 14, 20-26 (1992).
7. Hsieh CL, Bowcock AM, Farrer LA et al. Somat Cell Genet 16, 567-574 (1990).
8. Inayama Y, Yoneda H, Sakai T et al. Am J Med Genet 67, 103-105 (1996).
9. Williams J, Spurlock G, McGuffin P et al. Lancet 347, 1294-1296 (1996).
10. Erdmann J, Shimron-Abarbanell D, Rietschel M et al. Hum Genet 97, 614-619 (1996).
11. Arranz M, Collier D, Sodhi M et al. Lancet 346, 281-282 (1995).
12. Chen CH, Lee YR, Wei FC et al. Psychiatr Genet 7, 35-38 (1997).
13. Warren JT, Peacock ML, Rodriguez LC et al. Hum Mol Genet 2, 338 (1993).
14. Collier DA, Arranz MJ, Li T et al. Lancet 350, 1033-1034 (1997).
15. Enoch MA, Kaye WH, Rotondo A et al. Lancet 351, 1785-1786 (1998).
16. Verga M, Macclardi F, Cohen S et al. Am J Med Genet 74, 21-25 (1997).
17. Masellis M, Paterson AD, Badn F et al. Lancet 346, 1108 (1995).
18. Nothen MM, Rietschel M, Erdmann J et al. Lancet 346, 908-909 (1995).
19. Masellis M, Basile V, Meltzer HY et al. Neuropsychopharmacology 19, 123-132 (1998).
20. Overall JE and Gorham DR. Psychol Rep 10, 799-812 (1962).
21. Kane J, Honigfeld G, Singer J et al. Arch Gen Psychiatry 45, 789-796 (1988).
22. Hallmayer J, Kennedy JL, Wetterberg L et al. Arch Gen Psychiatry 49, 216-219 (1992).
23. Coon H, Jensen S, Holik J et al. Am J Med Genet 54, 59-71 (1994).
24. Barr CL, Kennedy JL, Pakslis AJ et al. Am J Med Genet 54, 51-58 (1994).
25. Karayiorgou M, Kasch L, Lasseter VK et al. Am J Med Genet 54, 345-353 (1994).